SurModics Inc - Asset Resilience Ratio
SurModics Inc (SRDX) has an Asset Resilience Ratio of 3.80% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SurModics Inc (SRDX) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2024)
This chart shows how SurModics Inc's Asset Resilience Ratio has changed over time. See SRDX book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down SurModics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SRDX market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $6.45 Million | 3.8% |
| Total Liquid Assets | $6.45 Million | 3.80% |
Asset Resilience Insights
- Limited Liquidity: SurModics Inc maintains only 3.80% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SurModics Inc Industry Peers by Asset Resilience Ratio
Compare SurModics Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for SurModics Inc (1999–2024)
The table below shows the annual Asset Resilience Ratio data for SurModics Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-09-30 | 2.24% | $4.00 Million | $178.56 Million | +0.12pp |
| 2023-09-30 | 2.12% | $3.93 Million | $185.73 Million | -- |
| 2022-09-30 | 0.00% | $0.00 | $158.36 Million | -- |
| 2021-09-30 | 3.97% | $7.72 Million | $194.59 Million | -14.00pp |
| 2020-09-30 | 17.96% | $30.31 Million | $168.76 Million | +2.37pp |
| 2019-09-30 | 15.60% | $24.93 Million | $159.87 Million | -9.60pp |
| 2018-09-30 | 25.19% | $41.35 Million | $164.13 Million | +1.91pp |
| 2017-09-30 | 23.28% | $31.80 Million | $136.59 Million | +6.76pp |
| 2016-09-30 | 16.52% | $21.95 Million | $132.89 Million | -- |
| 2015-09-30 | 0.00% | $0.00 | $100.21 Million | -- |
| 2014-09-30 | 2.90% | $3.04 Million | $104.89 Million | -7.12pp |
| 2013-09-30 | 10.02% | $10.21 Million | $101.92 Million | -3.57pp |
| 2012-09-30 | 13.59% | $14.12 Million | $103.87 Million | +4.23pp |
| 2011-09-30 | 9.36% | $15.23 Million | $162.65 Million | +4.01pp |
| 2010-09-30 | 5.35% | $9.11 Million | $170.28 Million | +0.53pp |
| 2009-09-30 | 4.81% | $8.93 Million | $185.56 Million | -0.03pp |
| 2008-09-30 | 4.84% | $9.25 Million | $191.03 Million | -2.45pp |
| 2007-09-30 | 7.29% | $12.50 Million | $171.33 Million | -27.69pp |
| 2006-09-30 | 34.98% | $55.06 Million | $157.40 Million | +18.46pp |
| 2005-09-30 | 16.52% | $20.52 Million | $124.22 Million | +1.49pp |
| 2004-09-30 | 15.04% | $16.51 Million | $109.78 Million | +12.34pp |
| 2003-09-30 | 2.70% | $2.64 Million | $97.81 Million | -2.40pp |
| 2002-09-30 | 5.10% | $3.94 Million | $77.25 Million | -4.46pp |
| 2001-09-30 | 9.57% | $5.80 Million | $60.58 Million | -21.66pp |
| 2000-09-30 | 31.23% | $15.85 Million | $50.75 Million | +19.04pp |
| 1999-09-30 | 12.19% | $3.90 Million | $32.00 Million | -- |
About SurModics Inc
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision o… Read more